Nucleoside

Results: 353



#Item
211Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology

Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology

Add to Reading List

Source URL: www.fda.gov

Language: English
212serum phosphorus in patients at risk. Avoid administering ATRIPLA with concurrent or recent use of nephrotoxic drugs[removed]HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed

serum phosphorus in patients at risk. Avoid administering ATRIPLA with concurrent or recent use of nephrotoxic drugs[removed]HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2011-09-23 12:47:19
213HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VIRAMUNE XR safely and effectively. See full prescribing information for VIRAMUNE XR. VIRAMUNE XR® (nevirapine) ext

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VIRAMUNE XR safely and effectively. See full prescribing information for VIRAMUNE XR. VIRAMUNE XR® (nevirapine) ext

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-01-28 14:06:57
214APPENDIX I  THE PRESIDENT’S EMERGENCY PLAN FOR AIDS RELIEF SOURCES OF FUNDING (Dollars in Millions)

APPENDIX I THE PRESIDENT’S EMERGENCY PLAN FOR AIDS RELIEF SOURCES OF FUNDING (Dollars in Millions)

Add to Reading List

Source URL: www.pepfar.gov

Language: English - Date: 2014-09-01 00:42:39
215HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VIRAMUNE safely and effectively. See full prescribing information for VIRAMUNE. Viramune® (nevirapine) tablets 200

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VIRAMUNE safely and effectively. See full prescribing information for VIRAMUNE. Viramune® (nevirapine) tablets 200

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2010-01-20 12:04:30
2161  HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use EDURANT® safely and effectively. See full prescribing information for EDURANT.

1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use EDURANT® safely and effectively. See full prescribing information for EDURANT.

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2012-12-10 17:41:28
217HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ISENTRESS safely and effectively. See full prescribing information for ISENTRESS. ®

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ISENTRESS safely and effectively. See full prescribing information for ISENTRESS. ®

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2011-12-23 12:58:35
218

PDF Document

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2012-08-15 16:02:38
219HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ISENTRESS safely and effectively. See full prescribing information for ISENTRESS. ®

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ISENTRESS safely and effectively. See full prescribing information for ISENTRESS. ®

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2012-08-15 16:02:36
220EVIDENCE REVIEW: Severe Combined Immunodeficiency (SCID)

EVIDENCE REVIEW: Severe Combined Immunodeficiency (SCID)

Add to Reading List

Source URL: www.hrsa.gov

Language: English - Date: 2012-01-07 00:53:35